MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
249 Approvals
Showing 1 to 20 of 249 approvalsPage 1 of 13

ROSWERA FILM-COATED TABLETS 5MG

Approval Number: SIN16659P
Approval: Dec 29, 2022

ROSWERA FILM-COATED TABLETS 20MG

Approval Number: SIN16657P
Approval: Dec 29, 2022

ROSWERA FILM-COATED TABLETS 10MG

Approval Number: SIN16658P
Approval: Dec 29, 2022

VORICONAZOLE MYLAN POWDER FOR SOLUTION FOR INJECTION 200 MG/VIAL

Approval Number: SIN16656P
Approval: Dec 20, 2022
mylan pharmaceuticals pte. ltd.

ROYCE RIFAMPICIN CAPSULE 150MG

Approval Number: SIN16652P
Approval: Dec 7, 2022

ROYCE RIFAMPICIN CAPSULE 300MG

Approval Number: SIN16653P
Approval: Dec 7, 2022

SERNADE FILM-COATED TABLET 50 MG

Approval Number: SIN16649P
Approval: Dec 1, 2022

CO-MIDIS TABLETS 80MG/5MG

Approval Number: SIN16647P
Approval: Nov 24, 2022

EXEDRAL 25 FILM-COATED TABLET 25MG

Approval Number: SIN16646P
Approval: Nov 22, 2022

HIBRUKA TABLET 50MG

Approval Number: SIN16645P
Approval: Nov 22, 2022

AXCEL CEPHALEXIN-250 CAPSULE 250MG

Approval Number: SIN16644P
Approval: Nov 21, 2022

TELCORD 80 TABLET 80 MG

Approval Number: SIN16639P
Approval: Nov 11, 2022

TELCORD 40 TABLET 40 MG

Approval Number: SIN16640P
Approval: Nov 11, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.